Literature DB >> 25680412

Crucial microRNAs and genes of human primary breast cancer explored by microRNA-mRNA integrated analysis.

Yang Yang1, Yiqiao Xing, Chaoqun Liang, Liya Hu, Fei Xu, Yuan Chen.   

Abstract

This study aimed to screen potential microRNAs (miRNAs) and genes related to human primary breast cancer. The gene and miRNA expression profile data of GSE19783 was obtained from Gene Expression Omnibus. The matched messenger RNA (mRNA) and miRNA expression profiles of 100 human primary breast cancer samples were chosen for further analysis. The miRNA-gene regulatory modules were screened via iterative multiplicative updating algorithm. The potential functions of genes in modules were predicted by functional and pathway enrichment analysis; meanwhile, the potential functions of miRNAs were predicted by functional enrichment analysis. Furthermore, miRNA-miRNA functional synergistic network and miRNA-miRNA co-regulatory network were constructed. Totally, 16 miRNA-gene modules were screened, containing 222 miRNA-gene interactions. The genes in these modules were mainly related to breast cancer. Genes in module 6 (e.g., SFRP1) were enriched in cell junction assembly; genes in module 8 and 12 (e.g., ESR1 and ERBB4) were significantly implicated in mammary gland alveolus and lobule development. Meanwhile, genes in module 12 (e.g., ERBB4) were enriched in the pathway of endocytosis. Besides, several miRNAs (e.g., miR-375) were enriched in inflammatory cell apoptotic process; some other miRNAs (e.g., miR-139-5p and miR-9) were enriched in response to vitamin D. Additionally, miR-139-5p with several other miRNAs (e.g., miR-9) co-regulated SFRP1; miR-375, miR-592, and miR-135a co-regulated ESR1 and ERBB4. Some miRNAs (e.g., miR-139-5p and miR-9) and their target gene SFRP1, as well as several other miRNAs (e.g., miR-375, miR-592, and miR-135a) and their target genes (e.g., ESR1 and ERBB4), might be crucial in the pathogenesis of primary breast cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25680412     DOI: 10.1007/s13277-015-3227-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  43 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Reduced expression of Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease.

Authors:  T Sauer; M K Pedersen; K Ebeltoft; O Naess
Journal:  Cytopathology       Date:  2005-08       Impact factor: 2.073

3.  Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors.

Authors:  Rebeca Sanz-Pamplona; Ramón Aragüés; Keltouma Driouch; Berta Martín; Baldo Oliva; Miguel Gil; Susana Boluda; Pedro L Fernández; Antonio Martínez; Víctor Moreno; Juan J Acebes; Rosette Lidereau; Fabien Reyal; Marc J Van de Vijver; Angels Sierra
Journal:  Am J Pathol       Date:  2011-06-25       Impact factor: 4.307

4.  Identification of differentially expressed microRNAs in human male breast cancer.

Authors:  Ulrich Lehmann; Thomas Streichert; Benjamin Otto; Cord Albat; Britta Hasemeier; Henriette Christgen; Elisa Schipper; Ursula Hille; Hans H Kreipe; Florian Länger
Journal:  BMC Cancer       Date:  2010-03-23       Impact factor: 4.430

5.  Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

Authors:  Frederik Holst; Phillip R Stahl; Christian Ruiz; Olaf Hellwinkel; Zeenath Jehan; Marc Wendland; Annette Lebeau; Luigi Terracciano; Khawla Al-Kuraya; Fritz Jänicke; Guido Sauter; Ronald Simon
Journal:  Nat Genet       Date:  2007-04-08       Impact factor: 38.330

6.  Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells.

Authors:  Sabine Kasimir-Bauer; Oliver Hoffmann; Diethelm Wallwiener; Rainer Kimmig; Tanja Fehm
Journal:  Breast Cancer Res       Date:  2012-01-20       Impact factor: 6.466

7.  A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules.

Authors:  Shihua Zhang; Qingjiao Li; Juan Liu; Xianghong Jasmine Zhou
Journal:  Bioinformatics       Date:  2011-07-01       Impact factor: 6.937

8.  miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10.

Authors:  Yating Chen; Jin Zhang; Huijun Wang; Jiayi Zhao; Cheng Xu; Yingying Du; Xin Luo; Fengyun Zheng; Rui Liu; Hongwei Zhang; Duan Ma
Journal:  BMC Cancer       Date:  2012-03-23       Impact factor: 4.430

9.  PathwayVoyager: pathway mapping using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database.

Authors:  Eric Altermann; Todd R Klaenhammer
Journal:  BMC Genomics       Date:  2005-05-03       Impact factor: 3.969

10.  miRecords: an integrated resource for microRNA-target interactions.

Authors:  Feifei Xiao; Zhixiang Zuo; Guoshuai Cai; Shuli Kang; Xiaolian Gao; Tongbin Li
Journal:  Nucleic Acids Res       Date:  2008-11-07       Impact factor: 16.971

View more
  5 in total

1.  MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/β-catenin signaling pathway.

Authors:  Fang Wu; Jun Li; Ni Guo; Xiao-Hui Wang; Yu-Qian Liao
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Up-regulation of microRNA-135a protects against myocardial ischemia/reperfusion injury by decreasing TXNIP expression in diabetic mice.

Authors:  Hong-Jun Zhu; De-Guo Wang; Ji Yan; Jian Xu
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

3.  DNAJC12 as a Mediator Between ESR1 and ERBB4 in Breast Carcinoma Cells.

Authors:  Mianjie Lin; Ya-Nan Wang; Yixin Ye; Zhelei Xiong; Fengbiao Guo; Haibin Chen
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

Review 4.  Role of Secreted Frizzled-Related Protein 1 in Early Mammary Gland Tumorigenesis and Its Regulation in Breast Microenvironment.

Authors:  Alisson Clemenceau; Caroline Diorio; Francine Durocher
Journal:  Cells       Date:  2020-01-14       Impact factor: 6.600

Review 5.  Breast Cancer and Microcalcifications: An Osteoimmunological Disorder?

Authors:  Alisson Clemenceau; Laetitia Michou; Caroline Diorio; Francine Durocher
Journal:  Int J Mol Sci       Date:  2020-11-15       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.